Princeton, NJ, United States of America

Lei Tang

This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Marion Roussel. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lei Tang. Retrieved from https://idiyas.com/inventor/lei-tang-x414jtxf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lei Tang - Innovator in Convulsion Treatment

Introduction

Lei Tang is a notable inventor based in Princeton, NJ (US). She has made significant contributions to the field of medicine, particularly in the treatment of convulsions. Her innovative approach has led to the development of a unique method that offers relief to patients suffering from this condition.

Latest Patents

Lei Tang holds a patent for the use of unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines. This invention relates to a method of treating a patient in need of relief from convulsions. The method comprises administering a convulsion-alleviating amount of a compound of the specified formula, where R, R¹, R², R³, R⁴, m, and n are defined within the patent documentation. She has 1 patent to her name.

Career Highlights

Throughout her career, Lei Tang has worked with Hoechst Marion Roussel, a company known for its commitment to pharmaceutical innovation. Her work has been instrumental in advancing treatment options for patients with convulsive disorders.

Collaborations

Lei has collaborated with esteemed colleagues, including Francis Parker Huger and Craig P. Smith. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

In summary, Lei Tang is a pioneering inventor whose work in convulsion treatment has the potential to improve the lives of many patients. Her dedication to innovation and collaboration continues to drive advancements in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…